L-5-Methyltetrahydrofolatus calcium 151533-22-1 est naturaliter occurrentes sal formans methyl derivatio folatium. 5-mthf *, also known as l-methylfolate, forma maxime biologice activa et functionis folatium et facilius absorbetur quam folata. Commune folatum converti debet ad l-methylfolatum ut participet duas metabolicae meatus principales.: methylation et DNA synthesis. Sola forma gratuiti folati in plasmate et cellulis humanis adest 5-mthf. Defectus acidi folici plerumque causari solet ex insufficiens effusio propter defectum vitaminum.. Acidum folicum augeri debet in graviditate et thorace, tum in pueritia incrementum. Cibus folatis-dives praestare non potest dose per effusio vel metabolicae mutationes vel medicamenta, ideo supplendum est.
1. L-5-MTHF Ca maxime pro acido folico antagonists (ut methotrexate, pyrimethamine, benzyl cefalexin et trimethoprim) antidotum, it's usually used for prevention of methotrexate dose or overdose treatment caused severe toxic effects.
2. L-5-MTHF Ca is used for Folic acid treatment of the following diseases, such as inflammatory diarrhea
and protein-energy malnutrition (poor nutrition), pregnancy or infancy megaloblastic anemia caused by poor.
3. L-5-MTHF Ca as adjuvant therapy for colon cancer, rectalis cancer.
4. Combined with 5-FU and treatment of digestive tract tumors or other 5-FU-sensitive tumors.High-dose CF used in conjunction with 5-FU (LF), the basic programme is currently the treatment of colon and rectal cancer.
5. L-5-MTHF Ca is used For children with leukemia, lymphoma, and osteosarcoma, such as high dose MTX treatment when rescued.
